Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB26FQ94Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,061
Award facts
- Contract value 100% obligated
- $7,061.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,061.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CIMZIA 2x200 mg/ml syringe kits, with an ultimate completion date of November 12, 2025. CIMZIA is a biologic immunosuppressant used to treat inflammatory conditions such as rheumatoid arthritis and Crohn's disease. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order represents one of numerous small-to-medium value transactions issued against the broader IDC, demonstrating AmerisourceBergen's ongoing role in fulfilling specialized pharmaceutical supply needs across the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FQ94Q?
SPE2DB26FQ94Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FQ94Q worth?
The government has obligated $7,061 on SPE2DB26FQ94Q.
Is contract SPE2DB26FQ94Q an order under another contract?
Yes. SPE2DB26FQ94Q is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ94Q competed?
The extent of competition for SPE2DB26FQ94Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award